logo Kompas.id
β€Ί
Englishβ€Ί181 Million Targeted for...
Iklan

181 Million Targeted for Covid-19 Vaccination

As many as 181 million people in Indonesia have been targeted to receive COVID-19 vaccinations so that herd immunity can be achieved. Meanwhile, regional administrations are making preparations for mass vaccination.

By
Kompas Team
Β· 1 menit baca
https://cdn-assetd.kompas.id/zkSSLNKWUhlGBEbcMzBZELZHCLY=/1024x683/https%3A%2F%2Fkompas.id%2Fwp-content%2Fuploads%2F2020%2F08%2FCORRECTION-INDONESIA-HEALTH-VIRUS_91082739_1597244671.jpg
AFP/BAY ISMOYO

An employee works on the production line of COVID-19 coronavirus vaccines at the Bio Farma Pharmacy, which will produce the vaccine early next year with a production capacity of 250 million vaccines a year, in Bandung, West Java on August 12, 2020. - Indonesia on August 11 launched human trials of a Chinese-made coronavirus vaccine with some 1,600 volunteers slated to take part in the six-month study.

As many as 181 million people in Indonesia have been targeted to receive COVID-19 vaccinations so that herd immunity can be achieved. Meanwhile, regional administrations are making preparations for mass vaccination.

JAKARTA, KOMPAS β€” The government is attempting to procure 329 million doses of COVID-19 vaccines from four companies. However, the government may increase the figure and procure as many as 334 million doses. This could secure a sufficient supply to vaccinate the targeted 181 million people.

Editor:
naranasrullah
Bagikan